USA Financial Formulas Acquires 5,816 Shares of MetLife, Inc. $MET

USA Financial Formulas bought a new stake in MetLife, Inc. (NYSE:MET – Free Report) in the third quarter, HoldingsChannel reports. The institutional investor bought 5,816 shares of the financial services provider’s stock, valued at approximately $548,000.

Several other institutional investors also recently made changes to their positions in the stock. Nvwm LLC grew its stake in shares of MetLife by 655.3% during the 3rd quarter. Nvwm LLC now owns 287 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 249 shares during the period. Mowery & Schoenfeld Wealth Management LLC purchased a new position in shares of MetLife in the 2nd quarter valued at about $26,000. Burk Holdings LLC purchased a new position in shares of MetLife in the 2nd quarter valued at about $27,000. Highland Investment Advisors LLC acquired a new stake in shares of MetLife in the second quarter valued at about $30,000. Finally, Elevation Wealth Partners LLC lifted its stake in shares of MetLife by 123.5% in the third quarter. Elevation Wealth Partners LLC now owns 362 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 200 shares during the period. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently commented on MET shares. Wall Street Zen raised shares of MetLife from a “hold” rating to a “buy” rating in a report on Sunday, September 27th. Jefferies Financial Group increased their target price on shares of MetLife from $103.00 to $115.00 and gave the company a “buy” rating in a report on Monday, August 10th. Atlantic Securities set a $103.00 target price on shares of MetLife in a report on Wednesday, July 15th. UBS Group lifted their price target on shares of MetLife from $105.00 to $110.00 and gave the company a “buy” rating in a research report on Tuesday, October 6th. Finally, JPMorgan Chase & Co. boosted their price target on MetLife from $108.00 to $110.00 and gave the stock an “overweight” rating in a research note on Thursday. Thirteen investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, MetLife has a consensus rating of “Moderate Buy” and an average target price of $105.19.

Read Our Latest Analysis on MetLife

MetLife Stock Up 0.5%

MetLife stock opened at $100.73 on Friday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.20 and a current ratio of 0.20. The firm has a market capitalization of $64.82 billion, a price-to-earnings ratio of 19.30, a price-to-earnings-growth ratio of 0.95 and a beta of 0.78. MetLife, Inc. has a fifty-two week low of $67.33 and a fifty-two week high of $102.43. The stock’s fifty day moving average is $96.87 and its two-hundred day moving average is $88.73.

MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.30 by $0.13. The business had revenue of $13.52 billion during the quarter, compared to the consensus estimate of $19.67 billion. MetLife had a return on equity of 23.39% and a net margin of 4.57%. The business’s revenue was up 10.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.02 EPS. Analysts predict that MetLife, Inc. will post 9.93 EPS for the current fiscal year.

MetLife declared that its Board of Directors has initiated a share repurchase program on Wednesday, August 5th that allows the company to repurchase $3.00 billion in outstanding shares. This buyback authorization allows the financial services provider to buy up to 4.8% of its shares through open market purchases. Stock buyback programs are often an indication that the company’s leadership believes its stock is undervalued.

MetLife Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 8th. Investors of record on Tuesday, November 3rd will be paid a $0.5925 dividend. This represents a $2.37 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, November 3rd. MetLife’s dividend payout ratio is presently 45.40%.

MetLife News Summary

Here are the key news stories impacting MetLife this week:

  • Positive Sentiment: JPMorgan raised its price target for MetLife from $108 to $110 and maintained an “overweight” rating. The new target implies approximately 9% upside from the referenced share price, signaling continued confidence in MetLife’s earnings outlook and valuation.
  • Positive Sentiment: Dowling & Partners increased its FY2026 EPS forecast to $10.30 from $10.10. The revised estimate is also above the broader consensus forecast of $9.90, suggesting expectations for stronger profitability. MetLife Hits New 52-Week High on Analyst Upgrade
  • Positive Sentiment: MetLife reached a new 52-week high following an analyst upgrade. The move reflects sustained investor demand and momentum around the insurer’s earnings performance and analyst outlook. MetLife Hits New 52-Week High on Analyst Upgrade
  • Positive Sentiment: Brokerages’ consensus price target is reported at $105.06, providing additional evidence that analysts see potential upside for MET. MetLife Consensus Price Target
  • Neutral Sentiment: MetLife Foundation awarded a $1 million grant to Ascendus for its Get Ready program. The initiative supports financial preparedness and may enhance MetLife’s corporate reputation, but it is unlikely to materially affect near-term earnings. Ascendus Expands Get Ready Program
  • Neutral Sentiment: Articles about concerts, NFL venues and events at MetLife Stadium concern the stadium’s entertainment operations, not MetLife, Inc.’s insurance and financial-services business, so they are not expected to influence MET materially.

MetLife Company Profile

(Free Report)

MetLife, Inc (NYSE: MET) is a global financial services company that provides insurance, retirement, and employee benefits solutions to individuals, employers, and institutions. Its offerings include life insurance, dental and vision coverage, accident and disability insurance, annuities, retirement savings products, and related financial services.

Through its institutional and workplace businesses, MetLife helps employers provide benefits and retirement programs to their employees. The company also serves individual customers with protection and income products.

Recommended Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.